-
-
-
-
-
-
-
Canaccord Starts Twist Bioscience (TWST) at Buy
-
-
-
-
-
-
-
Twist Bioscience (TWST) PT Raised to $68 at TD Cowen
-
-
-
-
-
-
-
Twist Bioscience licenses bispecific antibody platform from Invenra
-
-
-
-
-
-
-
Twist Bioscience co-authors study on AI protein design biosecurity risks
-
-
-
-
-
-
-
Leerink Partners Reiterates Market Perform Rating on Twist Bioscience (TWST)
-
-
-
-
-
-
-
Twist Bioscience (TWST) PT Raised to $62 at Scotiabank
-
-
-
-
-
-
-
Twist Bioscience (TWST) PT Raised to $48 at Baird
-
456,600 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

